Of interest, BK-promoted effects on the proliferation rate was significantly decreased in the presence of the P2X7 receptor antagonist A438079 (Figure 11C), suggesting that kininergic-purinergic signaling cross talking is required for BK-dependent cancer cell proliferation. The gene discussed is P2RX7; the disease is cancer.